OTHER
Device
Varian Medical Systems, Inc.
Total Payments
$10.0M
Transactions
584
Doctors
193
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3,357 | 80 | 64 |
| 2021 | $359,928 | 2 | 2 |
| 2020 | $1.4M | 115 | 34 |
| 2019 | $5.6M | 163 | 47 |
| 2018 | $1.1M | 88 | 35 |
| 2017 | $1.6M | 136 | 49 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.7M | 108 | 57.0% |
| Consulting Fee | $3.0M | 227 | 29.5% |
| Royalty or License | $1.0M | 17 | 10.2% |
| Gift | $186,061 | 5 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51,754 | 23 | 0.5% |
| Travel and Lodging | $43,304 | 74 | 0.4% |
| Education | $28,995 | 6 | 0.3% |
| Charitable Contribution | $10,000 | 2 | 0.1% |
| Food and Beverage | $6,221 | 122 | 0.1% |
Payments by Type
Research
$5.7M
108 transactions
General
$4.3M
476 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Strategic Collaboration Agreement - MD Anderson | Varian Medical Systems, Inc. | $2.0M | 0 |
| MRA with WU | Varian Medical Systems, Inc. | $449,896 | 0 |
| Phase II trial of SRT to induce SDR- UT | Varian Medical Systems, Inc. | $386,100 | 0 |
| Phase III Study of SR versus SAbR- UTSW | Varian Medical Systems, Inc. | $340,000 | 0 |
| MRA with U Michigan | Varian Medical Systems, Inc. | $306,311 | 0 |
| Radiotherapy and Immunotherapy for metastatic Cancer-Leland | Varian Medical Systems, Inc. | $250,000 | 0 |
| Thalamotomy Study - UAB | Varian Medical Systems, Inc. | $150,020 | 0 |
| Phase II Trial of Virtual Cone Trigeminal - UAB | Varian Medical Systems, Inc. | $144,778 | 0 |
| MRA with BWH | Varian Medical Systems, Inc. | $144,047 | 0 |
| Fresolimumab and SAR - Stanford (Genzyme) | Varian Medical Systems, Inc. | $133,333 | 0 |
| MRA with UCSD | Varian Medical Systems, Inc. | $125,000 | 0 |
| MRA with UCLA | Varian Medical Systems, Inc. | $122,500 | 0 |
| Health outcomes and cost analysis of surgery-SCRI | Varian Medical Systems, Inc. | $93,957 | 0 |
| Immune Response & Local Microbiome | Varian Medical Systems, Inc. | $86,250 | 0 |
| A STUDY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | DERMIRA, INC. | $78,598 | 0 |
| DELTIC - U. Louisville | Varian Medical Systems, Inc. | $75,000 | 0 |
| Phase II Study of I.SBRT vs. TACE - L.C. | Varian Medical Systems, Inc. | $74,000 | 0 |
| TGF-b with UCSF | Varian Medical Systems, Inc. | $70,120 | 0 |
| Study of TACE versus SBRT- Leland | Varian Medical Systems, Inc. | $70,000 | 0 |
| MRA with Fox Chase Cancer Center | Varian Medical Systems, Inc. | $56,671 | 0 |
Top Doctors Receiving Payments for OTHER — Page 7
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Cardiovascular Disease | Naperville, IL | $34.29 | 1 |
| , MD | Cardiovascular Disease | Naperville, IL | $34.29 | 1 |
| , MD | Cardiovascular Disease | Naperville, IL | $34.29 | 1 |
| , M.D | Internal Medicine | Bartlett, TN | $31.04 | 1 |
| , M.D | Cardiovascular Disease | Kalamazoo, MI | $31.04 | 1 |
| , M.D | Internal Medicine | Cleveland, OH | $31.04 | 1 |
| , M.D | Cardiovascular Disease | Kalamazoo, MI | $31.04 | 1 |
| , D.D.S | General Practice | Maple Heights, OH | $30.00 | 1 |
| , M.B. B.CH | Student in an Organized Health Care Education/Training Program | Augusta, GA | $28.94 | 1 |
| , MD | Cardiovascular Disease | Louisville, KY | $25.09 | 1 |
| , APRN-NP | Nurse Practitioner | Louisville, KY | $25.09 | 1 |
| , MD | Cardiovascular Disease | Jacksonville, FL | $23.13 | 1 |
| , MD | Cardiovascular Disease | Jacksonville, FL | $23.13 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Morristown, NJ | $23.07 | 1 |
| , M.D | Cardiovascular Disease | Morristown, NJ | $23.07 | 1 |
| , PA | Physician Assistant | Springfield, NJ | $23.07 | 1 |
| , AGACNP-BC | Acute Care | New York, NY | $23.07 | 1 |
| , M.D | Cardiovascular Disease | New York, NY | $23.07 | 1 |
| , MD | Cardiovascular Disease | Chambersburg, PA | $22.40 | 1 |
| , DO | Cardiovascular Disease | York, PA | $22.40 | 1 |
| James Gentry | Cardiovascular Disease | Nashville, TN | $22.34 | 1 |
| , MD | Internal Medicine | Nashville, TN | $22.34 | 1 |
| , MD | Cardiovascular Disease | Nashville, TN | $22.34 | 1 |
| , M.D | Cardiovascular Disease | Nashville, TN | $22.34 | 1 |
| , MD, PHD | Radiation Oncology | Palo Alto, CA | $22.08 | 1 |
Ad
Manufacturing Companies
- Varian Medical Systems, Inc. $9.9M
- DERMIRA, INC. $81,791
- CARDIVA MEDICAL, INC. $3,357
- Stryker Corporation $2,955
- Boston Scientific Corporation $2,400
- Kerr Corporation $30.00
Product Information
- Type Device
- Total Payments $10.0M
- Total Doctors 193
- Transactions 584
About OTHER
OTHER is a device associated with $10.0M in payments to 193 healthcare providers, recorded across 584 transactions in the CMS Open Payments database. The primary manufacturer is Varian Medical Systems, Inc..
Payment data is available from 2017 to 2024. In 2024, $3,357 was paid across 80 transactions to 64 doctors.
The most common payment nature for OTHER is "Unspecified" ($5.7M, 57.0% of total).
OTHER is associated with 20 research studies, including "Strategic Collaboration Agreement - MD Anderson" ($2.0M).